Glenmark to start another new Phase 3 clinical trial on a combination of 2 anti-viral drugs Favipiravir & Umifenovir
NE BUSINESS BUREAU MUMBAI, MAY 27 Glenmark Pharmaceuticals has announced, on Tuesday, a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifeno…
